Therapeutic Area:	Multiple Sclerosis	22 Days Left to Participate
Number of Contributors:	101
Target Completion Date:	June 2013
Project Progress:
Protocol Builder Results:	Click here to view report

Why lisinopril in multiple sclerosis (MS):

• Multiple sclerosis is a disease of the immune system which acts against patients' own nervous system cells.  Available therapies modulate the immune system
• Treatments are modestly effective, but all have undesired side effects, some serious
• Lisinopril (an ACE inhibitor) is a drug that has been used in millions of patients worldwide for years as a safe and effective treatment for hypertension
• Lisinopril has been tested in well-established animal models of MS. Results provide compelling evidence that ACE inhibitors modulate immune response
• Lisinopril can be tested for efficacy in patients with MS; if clinical studies confirm its utility, as an inexpensive solution it might provide a real alternative for thousands suffering with MS

 Please, take part in designing an innovative clinical study of lisinopril in MS!
- View Project Disclaimers (PDF)